Navigation Links
Alfacell Receives NASDAQ Delisting Letter
Date:8/1/2008

SOMERSET, N.J., Aug. 1 /PRNewswire-FirstCall/ -- Alfacell Corporation (Nasdaq: ACEL) today announced that it received a NASDAQ staff determination letter on July 29, 2008 notifying the Company that its securities will be delisted from The NASDAQ Capital Market. On June 25, 2008, NASDAQ notified the Company that the market value of its listed securities had been below the minimum $35 million required for continued inclusion on The NASDAQ Capital Market under Marketplace Rule 4310(c)(3)(B) for the previous 10 consecutive trading days. In accordance with Marketplace Rule 4310(c)(8)( C), the Company was provided with a grace period of 30 calendar days, or until July 25, 2008, to regain compliance with the minimum market value requirement. The staff determination letter states that the Company has not regained compliance within the given grace period and as a result, unless the Company requests an appeal of the staff determination, trading of the Company's common stock will be suspended at the opening of business on August 7, 2008, and a Form 25-NSE will be filed with the Securities and Exchange Commission, or the SEC, to remove the Company's securities from listing and registration on NASDAQ.

The staff determination letter further states that the Company may appeal the delisting determination to a NASDAQ Listing Qualification Panel, or the Panel, by submitting a hearing request. A hearing request will stay the suspension of the Company's securities and the filing of the Form 25-NSE pending the Panel's decision, if the Hearings Department receives the Company's hearing request on or before 4:00pm Eastern Time on August 5, 2008. The Company intends to timely submit a hearing request and to present its arguments and/or plan of complia
'/>"/>

SOURCE Alfacell Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Alfacell Receives NASDAQ Non-Compliance Notification
2. Alfacell Reports Financial Results for Third Quarter of Fiscal 2008
3. Alfacell Announces Retirement of Chief Executive Officer
4. Alfacell Reports Financial Results for Second Quarter of Fiscal 2008
5. Alfacell to Host Fiscal Second Quarter 2008 Financial Results Conference Call and Webcast
6. Alfacell Announces ONCONASE(R) Purchase and Supply Agreement with Scientific Protein Laboratories
7. Alfacell to Host Webinar on RNA Interference-Like Mechanics of RNase Therapeutics on Nov. 29
8. Alfacell to Host Fiscal Fourth Quarter and Year-End 2007 Financial Results Conference Call and Webcast
9. Alfacell to Present at BIO InvestorForum 2007
10. Silence Therapeutics Receives Allowance from United States Patent and Trademark Office for its Core RNAi Patent
11. Workforce Alliance Receives U.S. Labor Departments Excellence Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Dec. 14 Vermillion, Inc. (Pink ... announced William C. Wallen, Ph.D. Chief Scientific ... for IDEXX Laboratories, will be joining its ... bankruptcy plan. ,, "Bill brings more ... in diagnostics and biotechnology," said Gail Page, ...
(Date:12/14/2009)... Dec. 14 The third edition of ... , published by the Infusion Nurses ... for anthracycline extravasation.(1) Anthracyclines are a group ... epirubicin that have been used in the treatment ... 1970s.(2) ,, According to the INS ...
(Date:12/14/2009)... CARLOS, Calif., Dec. 14 Nektar Therapeutics ... Winger has been appointed to serve on its ... biopharmaceutical industry leader with over 35 years of ... ,, "Dennis brings to Nektar extensive industry perspective ... said Howard W. Robin, President and CEO of ...
(Date:12/14/2009)... -- , - Results From a ... Arthritis in Seven Major Industrialized Countries , , ... say their disease, impacts their ... living with rheumatoid arthritis find shopping for gifts, ... presents most, difficult to do, ...
Breaking Biology Technology:Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 3Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 4Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 2Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 3Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 4Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 5Dennis Winger Joins Nektar Therapeutics' Board of Directors 2Dennis Winger Joins Nektar Therapeutics' Board of Directors 3Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 2Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 3Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 4
... Inc.,(Nasdaq: NGSX ), a biopharmaceutical company focused on developing ... present,at the 2007 NewsMakers in the Biotech Industry Conference on ... Stephen Ghiglieri, Chief Financial Officer, will be presenting. ... Time: 2:00 p.m. ...
... HONG KONG, Aug. 27 /Xinhua-PRNewswire-FirstCall/ -- China Technology,Development ... today,announced the appointment of Charlene Hua as the ... pursuant to a board,resolution passed on the same ... Committee of the Company. As Chief Financial ...
... EDISON, N.J., Aug. 27 Heritage Pharmaceuticals Inc.,("Heritage") ... they,have entered in to a strategic alliance for ... for the U.S. prescription drug,market. Under the Agreement, ... ANDA submission and Heritage retains sales and marketing,rights ...
Other Biology Technology:NeurogesX to Present at BioCentury's NewsMakers in the Biotech Industry Conference 2NeurogesX to Present at BioCentury's NewsMakers in the Biotech Industry Conference 3China Technology Announces New Chief Financial Officer 2China Technology Announces New Chief Financial Officer 3Heritage and Ipca Enter Into Strategic Alliance for Generic Pharmaceutical Products 2
(Date:12/15/2009)... devastating brain diseases such as Alzheimer,s and Parkinson,s, doctors ... to help a patient. , But they come up ... of patients with ataxia disabling disorders that rob ... Florida neurologists are trying to change that with the ... National Institute of Neurological Disorders and Stroke to establish ...
(Date:12/15/2009)... and ancient American horses may have been grazing ... longer than previously thought. After plucking ancient DNA ... of researchers used cutting-edge techniques to uncover "genetic ... dated to between 7,600 and 10,500 calendar years. ... population of these now-extinct mammals endured longer in ...
(Date:12/15/2009)... exact an enormous emotional and economic toll on society. ... rip currents each year in U.S. waters and it,s likely ... worldwide. A serious disconnect exists between rip current research ... rip tides and undertows, and more importantly, most people do ... a rip current. , The goal of the Rip Current ...
Breaking Biology News(10 mins):UF to lead national effort to help patients with rare brain disease 2UF to lead national effort to help patients with rare brain disease 3Late-surviving megafauna exposed by ancient DNA in frozen soil 2Late-surviving megafauna exposed by ancient DNA in frozen soil 3Late-surviving megafauna exposed by ancient DNA in frozen soil 4Consumer Reports 3A Hearing Aid Shoppers Pay High Prices Get Mediocre Fittings 47551 1Consumer Reports 3A Hearing Aid Shoppers Pay High Prices Get Mediocre Fittings 47551 2Consumer Reports 3A Hearing Aid Shoppers Pay High Prices Get Mediocre Fittings 47551 3Consumer Reports 3A Hearing Aid Shoppers Pay High Prices Get Mediocre Fittings 47551 4Researchers Present Safety and Efficacy Results of 429 Patients Treated With Radiofrequency Ablation for Pre Cancerous Barretts Esophagus 4507 1Researchers Present Safety and Efficacy Results of 429 Patients Treated With Radiofrequency Ablation for Pre Cancerous Barretts Esophagus 4507 2Researchers Present Safety and Efficacy Results of 429 Patients Treated With Radiofrequency Ablation for Pre Cancerous Barretts Esophagus 4507 3Research Finds New Crop of Breast Cancer Genes 47543 1Research Finds New Crop of Breast Cancer Genes 47543 2
... the most common infectious disease transmitted by mosquitoes ... Researchers at the Hygiene Institute at Heidelberg University Hospital ... the location in the human cell where the virus ... exact process of viral replication and serves as a ...
... Amsterdam, the Netherlands: Scheduling more physical education time in ... levels, suggests new research that discovered those who got ... less at home while those who got little at ... at home. , The scientists, who presented their research ...
... are characterized by poor vegetative cover, strong winds, ... this context, the land resources of Abu Dhabi ... to various land degradation stresses, including wind erosion, ... land resources of Abu Dhabi Emirate, land degradation ...
Other Biology News:Visualizing virus replication in three dimensions 2Study finds children's activity levels not influenced by more PE time in school 2Wind, salt and water are leading indicators of land degradation in Abu Dhabi 2
For mRNA Differential Display with three one-base anchored oligo-dT primers and rationally designed arbitrary 13mers. These kits feature the latest generation of isotopic mRNA Differential Display t...
Request Info...
... 9 oligodeoxynucleotides are random ... at the 5' end ... Fluor dyes and they ... microarray spot morphology, hybridization ...
Topoisomerase I, isolated from wheat germ, is an enzyme capable of removing negative supercoils from covalently closed circular DNA (1)....
Biology Products: